Tom Gregory is a partner in the fraud investigation and dispute services practice of Ernst & Young LLP, where he focuses on leading complex investigations in the life sciences industry. He has over 20 years of experience performing detailed analyses involving fraud allegations, commercial litigation, government investigations, compliance assessments, audits and other significant business analysis.
Tom has conducted analyses of this type on behalf of management teams, boards of directors, law firms and regulatory authorities.
His experience focuses on the life sciences industry, including pharmaceutical and medical device companies, wholesalers, PBMs, biotechs, health insurers, physician practices, hospitals, long-term care and related sectors. Prior to joining EY, Tom served as Vice President at a major health services company, where his responsibilities included compliance auditing and investigations.
Tom has significant experience performing quantitative analysis to support the investigation and resolution of government investigations under the False Claims Act, the Anti-Kickback Statute and the Foreign Corrupt Practices Act. His experience includes all phases of the investigation and dispute resolution process up to and through damage calculations and presentations to regulators and enforcement officials in civil and criminal settings.